Year: 2025

IgniteData Selected for Microsoft for Startups Pegasus Program: Agentic AI Powers Archer Solution to Transform Clinical Trial Data Transfer

NEW CASTLE, Del., Sept. 24, 2025 /PRNewswire/ -- IgniteData, the healthtech company behind Archer—an advanced EHR-to-EDC solution delivering fully automated, regulatory-grade...

CLn Skin Care Launches FDA-Cleared Hypochlorous Spray for Sensitive and Irritated Skin Portable, Physician-Recommended Spray Offers Gentle Cleansing and Supports Natural Healing

CLn Skin Care, a leader in dermatologist-developed therapeutic skincare, is proud to announce the launch of its new Hypochlorous Acid...

A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...

A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's...

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition

New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment

During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every...

error: Content is protected !!